#antibiotic-access

Many patients, especially in resource-limited settings, cannot obtain timely microbiology, susceptibility testing, or the effective antibiotics needed to treat resistant infections.

Prioritize antibiotics with new targets or mechanisms against critical resistant pathogens and plan registration, manufacturing, supply and stewardship across income settings before approval.

Coordinate registration, procurement, quality assurance, forecasting and supply so patients can obtain effective Access and Reserve antibiotics without promoting uncontrolled use.

Align treatment guidance, essential-medicine lists and purchasing with WHO Access, Watch and Reserve categories so first-line Access antibiotics are available and higher-risk products are controlled.